ACIP Charter Revised Again Amid Leadership Shakeups
ACIP charter changes and HHS restructuring continue to unfold, with direct effects on how adult vaccine recommendations may be revisited.
- Revised...

Created by Frank Samide
Adult vaccine guidance, approvals, boosters and travel updates from CDC, FDA, WHO
Explore the latest content tracked by Adult Immunization Updates
ACIP charter changes and HHS restructuring continue to unfold, with direct effects on how adult vaccine recommendations may be revisited.
Global influenza activity has largely re-established pre-pandemic seasonal patterns, with northern hemisphere peaks typically December–March...
Growing data now backs giving multiple vaccines like flu and COVID together in one visit for adults.
No significant updates today.
No significant updates today.
Eli Lilly is acquiring three vaccine companies for nearly $4 billion to expand infectious disease prevention.
Panama's confirmation of two imported measles cases has prompted urgent calls to update vaccination schedules for adults alongside children at free immunization points nationwide.
Protein-based COVID-19 vaccines demonstrate superior tolerability to mRNA comparators, offering an alternative for adults concerned about side effects.
US health officials are weighing an XFG-targeted COVID vaccine for the 2026-27 season, as this subvariant now drives most US cases and manufacturers stand ready to produce it, even as WHO recommends LP.8.1 instead.
RSV infection carries important implications for older adults and public health strategies.
CDC continues to recommend one-time triple-panel screening for all adults 18+, separate from vaccination status. Recent changes to the newborn birth...
Clinics can raise pneumococcal uptake in adults 50+ through targeted workflow fixes.
Immunosenescence combined with gut microbiota shifts and mTOR overactivation sharply reduces vaccine responses in older adults.
Kira Ganga Kieffer argues that vaccine hesitancy reflects moral and existential concerns rather than ignorance of science.
A new model evaluated expanding age-based PCV recommendations from 65 to 50 using PCV20 or PCV21.